1
ModularCMC™
Flexible, phase-appropriate development and manufacturing of antibody-based therapeutics through integrated, modular work packages
Explore CMC ModulesHigh-Science, High-Touch
Wheeler Bio is a High-Science, High-Touch biologics CDMO advancing antibody-based therapeutics from discovery to the clinic and beyond.
Our ServicesDiscovery to Clinic
Providing expert support at every stage of development, from lead selection through cGMP manufacturing
Cell Line Development
Wheeler Bio’s mammalian cell line development (CLD) services combine advanced expression technologies and experienced teams, and are integrated into the ModularCMC platform to accelerate the path from discovery to commercial.
Learn More
Process Design Featuring ModularCMC™
Wheeler Bio’s ModularCMC platform delivers phase-appropriate, integrated work packages for process and analytical development. It enables rapid, data-driven advancement from discovery to cGMP supply while reducing risk through structured evaluation stop points.
Learn More
Drug Substance and Drug Product Manufacturing
Wheeler Bio provides integrated drug substance and drug product manufacturing for antibody therapeutics, providing non-GMP and cGMP production with high-quality, fully traceable material.
Learn More
IND and Regulatory CMC Support
Wheeler Bio, in partnership with Pharmefex, provides integrated IND and regulatory support to streamline development and accelerate clinical readiness, delivering strategic guidance, compliant documentation, and regulatory expertise from early development through IND submission.
Learn More
High-Science CMC
Advancing Antibody-Based Therapies
Wheeler Bio is relentless in our pursuit of innovative approaches to expedite our timelines, ensuring our partners’ programs progress rapidly without excessive risk.
2
Integrated cGMP
Drug substance and drug product manufacturing for antibody-based therapeutics, from early development through clinical supply with scalable cGMP production
Manufacturing Services
An Emerging Biotechnology Hub
U.S. Based Manufacturing
At Wheeler Bio, our Oklahoma based CDMO facilities reduce exposure to evolving compliance risk and program disruption. U.S. based manufacturing strengthens supply chain security, supports regulatory alignment, and provides the certainty needed to advance biologics scale-up with confidence.
News & Resources
Featured News + PR
OU–Industry Collaboration Harnesses AI to Accelerate Antibody Drug Production
Read More
Featured News + PR
Wheeler Bio Appoints Industry Veteran Patrick Lucy as Chief Executive Officer
Read More
Explore More
Stay ahead of the curve by diving into our curated hub of industry insights and expert resources.
Our Expert Team
Let’s Get Started
Wheeler Bio is excited to collaborate on the development of innovative antibody-based therapeutics. Contact us to learn how ModularCMC can accelerate biologics on the path to the clinic.